Phorbol ester induces a transient increase in α5β1-mediated adhesion of the megakaryoblastic cell line CHRF 288–11

Platelets

Volumn 10, Issue 42038, 1999, Pages 117-123

  Conran, Nicola ^a   Hemming, Frank W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

adhesion; CHRF 288 11; fibronectin; megakaryoblastic differentiation; PMA; 5 1 integrin

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; FIBRINOGEN; FIBRONECTIN; FIBRONECTIN RECEPTOR; INTEGRIN; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PLASTIC; VITRONECTIN;

ARTICLE; BINDING AFFINITY; BLOOD; BLOOD VESSEL WALL; BONE MARROW; CELL ADHESION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIGAND BINDING; MEGAKARYOBLAST; MEGAKARYOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TISSUE CULTURE;

EID: 0032933375     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537109909169173     Document Type: Article

References (33)

1. Fugman D A, Witte D P, Jones C LA, Aronow B J, Lieberman M A. In vitro establishment and characterisation of a human megakaryoblastic cell line. Blood 1990; 75: 1252 – 61
2. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium activated phospholipid protein kinase tumor promoting phorbol esters. J Biol Chem 1982; 257: 7847 – 51
3. Komatsu N, Nakauchi H, Miwa A, Ishihara T, Eguchi M, Moroi M, Okada M, Sato Y, Wada H, Yawata Y, Suda T, Miura Y. Establishment and characterisation of a human leukemic cell line with megakaryocytic features: Dependency on GM-CSF, IL-3 or Epo for growth and survival. Cancer Res 1991; 51: 341 – 8
4. Roth B J, Sledge G W Ir, Straneva J E, Brandt J, Goheen M, Hoffman R. Analysis of phorbol ester stimulated human megakaryocyte development. Blood 1988; 72: 202 – 7
5. Dorn G WII, Davis M G, D'Angelo D D. Gene expression during phorbol ester induced differentiation of cultured human megakaryoblastic cells. Am J Physiol 1994; 266: 1231 – 9
6. Murate T, Saga S, Hamagiin M, Asano H, Ito T, Watanabe T, Adachi K, Koizuni K T, Yoshida S, Saito H, Hoota T. Herbimycin A inhibits phorbol ester induced morphologic changes, adhesion and megakaryocytic differentiation of the leukemia cell line MEG-01. Proc Soc Exp Biol Med 1995; 209: 270 – 8
7. Mossuz P, Schweitzer A M, Berthier R. Expression and function of receptors for extracellular matrix molecules in the differentiation of human megakaryocytes in vitro. Br J Haematol 1997; 98: 819 – 27
8. Levesque J-P, Leavesley D I, Niutta S, Vadas M, Simmons P J. Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen(VLA)-4 and VLA-5 Integrins. J Exp Med 1995; 181: 1805 – 15
9. Phillips D R, Charo I F, Scarborough R M. GPIIb/IIIa-the responsive integrin. Cell 1991; 65: 359 – 62
10. Sonnenberg A, Modderman P W, Hogervorst F. Laminin receptor on platelets is the integrin VLA-6. Nature 1988; 336: 487 – 9
11. Shattil S J, Ginsberg M H, Brugge J S. Adhesive signalling in platelets. Curr Opin Cell Biol 1994; 6: 695 – 704
12. Hayman E G, Pierschbacher M D, Ruoslahti E. Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol 1985; 100: 1948 – 54
13. Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem 1988; 57: 375 – 413
14. Guan J L, Hynes R O. Lymphoid cells recognize an alternative spliced segment of fibronectin via the integrin receptor α4β1. Cell 1990; 60: 53 – 61
15. Buckley D, Doyannas R, Newton J P, Blystone S D, Brown E J, Watt S M, Simmons D L. Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J Cell Sei 1996; 109: 437 – 45
16. Caixia S, Stewart S, Wayner E, Carter W, Wilkins J. Antibodies to different members of the β1 (CD29) integrins induce homotypic and heterotypic cellular aggregation. Cell Immunol 1991; 138: 216 – 28
17. Weinacker A, Chen A, Agrez M, Cone R I, Nishimura S, Wayner E, Pytela R, Sheppard D. Role of the integrin αvβ6 in cell attachment to fibronectin. J Biol Chem 1994; 269: 6940 – 8
18. Cox D, Aoki T, Seki J, Motoyama Y, Yoshida K. Pentamidine is a specific, nonpeptide, GPIIb/lIIa antagonist. Thromb Haemost 1996; 75: 503 – 9
19. Larsson A, Lindahl T L. Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist. Upsala J Med Sci 1994; 99: 121 – 30
20. Foster M R, Pike N B, Hornby E J, Porter B, Eldred C D, Ross B C, Lumley P. GR14053, a potent and specific non-peptide fibrinogen receptor antagonist on human platelets in vitro. Thromb Haemost 1993; 69: 559s
21. Schick B P, Tang R P, Jacoby J A. Changes in protein sulfation in HEL, CHRF 288–11 and K562 cells following treatment with DMSO and PMA. Arch Biochem Biophys 1995; 317: 191 – 200
22. Zauli G, Bassini A, Catani L, Gibellini D, Celeghini C, Paola B, Caramelli E, Guidotti L, Capitani S. PMA-inducd megakaryocytic differentiation of HEL cells is accompanied by striking modifications of protein kinase C catalytic activity and isoform composition at the nuclear level. Br J Haematol 1996; 92: 530 – 6
23. Ogura M, Morishima Y, Okumura M, Hotta T, Takamoto S, Ohno R, Hirabayashi N, Nagura H, Saito H. Functional and morphological-differentiation induction of a human megakaryoblast leukemia-cell line (MEG-01s) by phorbol diesters. Blood 1988; 72: 49 – 60
24. Clark E A, Brugge J S. Integrins and signal transduction pathways: The road taken. Science 1995; 268: 233 – 9
25. Boudignon-Proudhan C, Patel P M, Parise L V. Phorbol ester enhances integrin αIIbβ3 dependent adhesion of human erythroleukemic cells to activation dependent monoclonal antibodies. Blood 1996; 87: 968 – 76
26. Conran N, Hemming F W. The effect of PMA-induced differentiation on the surface expression of integrins on CHRF 288–11 megakaryoblastic cells in culture. Platelets 1998; 9: 103 – 8
27. Vuori K, Ruoslahti E. Activation of PKC precedes α5β1 integrin-mediated cell spreading on fibronectin. J Biol Chem 1993; 268: 21459 – 62
28. Calvette J J. On the structure and function of platelet integrin αIIbβ3, the fibrinogen receptor. Proc Soc Exp Biol Med 1995; 208: 346 – 60
29. Kerst J M, Sanders J B, Slapercortenbach I CM, Doorakkers M C, Hooibrink B, Vanoers R HJ, Borne A EGKV, Vanderschoot C E. α4β1 and α5β1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation dependent way. Blood 1993; 81: 344 – 51
30. Gismondi A, Milella M, Palmieri G, Picolli M, Frati L, Santoni A. Stimulation of protein tyrosine phosphorylation by interaction of NK cells with fibronectin via α4β1 and α5β1. J Immunol 1995; 154: 3128 – 37
31. Danilov Y N, Juliano R L. Phorbol ester modulation of integrin-mediated adhesion: A post receptor event. J Cell Biol 1989; 108: 1925 – 33
32. Yamada A, Nikaido T, Nojima Y, et al. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol. 1991; 146: 53 – 6
33. Hanks S K, Calalb M B, Harper M C, Patel S K. Focal adhesion protein-tyrosine kinase phosphorylation in response to cell attachment to fibronectin. Proc Natl Acad Sci USA 1992; 89: 8487 – 91